1
Hadji, P., Papaioannou, N., Gielen, E., Tepie, M.F., Zhang, E., Frieling, I., Geusens, P., Makras, P., Resch, H., Möller, G., Kalouche-Khalil, L, Fahrleitner-Pammer, A.
Veröffentlicht in: Hadji , P , Papaioannou , N , Gielen , E , Tepie , M F , Zhang , E , Frieling , I , Geusens , P , Makras , P , Resch , H , Möller , G , Kalouche-Khalil , L & Fahrleitner-Pammer , A 2015 , ' Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study ' , Osteoporosis International , vol. 26 , no. 10 , pp. 2479-2489 . https://doi.org/10.1007/s00198-015-3164-4;
2015
Veröffentlicht in: Hadji , P , Papaioannou , N , Gielen , E , Tepie , M F , Zhang , E , Frieling , I , Geusens , P , Makras , P , Resch , H , Möller , G , Kalouche-Khalil , L & Fahrleitner-Pammer , A 2015 , ' Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study ' , Osteoporosis International , vol. 26 , no. 10 , pp. 2479-2489 . https://doi.org/10.1007/s00198-015-3164-4;
2015
2
Fahrleitner-Pammer, A., Papaioannou, N., Gielen, E., Tepie, M. Feudjo, Toffis, C., Frieling, I., Geusens, P., Makras, P., Boschitsch, E., Callens, J., Anastasilakis, A. D., Niedhart, C., Resch, H., Kalouche-Khalil, L., Hadji, P.
Veröffentlicht in: Fahrleitner-Pammer , A , Papaioannou , N , Gielen , E , Tepie , M F , Toffis , C , Frieling , I , Geusens , P , Makras , P , Boschitsch , E , Callens , J , Anastasilakis , A D , Niedhart , C , Resch , H , Kalouche-Khalil , L & Hadji , P 2017 , ' Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium ' , Archives of Osteoporosis , vol. 12 , no. 1 , 58 . https://doi.org/10.1007/s11657-017-0351-2;
2017
Veröffentlicht in: Fahrleitner-Pammer , A , Papaioannou , N , Gielen , E , Tepie , M F , Toffis , C , Frieling , I , Geusens , P , Makras , P , Boschitsch , E , Callens , J , Anastasilakis , A D , Niedhart , C , Resch , H , Kalouche-Khalil , L & Hadji , P 2017 , ' Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium ' , Archives of Osteoporosis , vol. 12 , no. 1 , 58 . https://doi.org/10.1007/s11657-017-0351-2;
2017
3
van den Berg, P., van Haard, P. M. M., van der Veer, E., Geusens, P. P., van den Bergh, J. P., Schweitzer, D. H.
Veröffentlicht in: van den Berg , P , van Haard , P M M , van der Veer , E , Geusens , P P , van den Bergh , J P & Schweitzer , D H 2018 , ' A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates ' , Osteoporosis International , vol. 29 , no. 4 , pp. 813-824 . https://doi.org/10.1007/s00198-017-4340-5;
2018
Veröffentlicht in: van den Berg , P , van Haard , P M M , van der Veer , E , Geusens , P P , van den Bergh , J P & Schweitzer , D H 2018 , ' A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates ' , Osteoporosis International , vol. 29 , no. 4 , pp. 813-824 . https://doi.org/10.1007/s00198-017-4340-5;
2018
4